DMX-5804 is a potent, orally active and selective MAP4K4 inhibitor, with an IC 50 of 3 nM, a pIC 50 of 8.55 for human MAP4K4, less potent on MINK1/MAP4K6 ( pIC 50 , 8.18), and TNIK/MAP4K7 ( pIC 50 , 7.96). DMX-5804 enhances cardiomyocyte survival, and reduces ischemia-reperfusion injury in mice.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Obesity | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > MAP4K
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.